Sean Mcgarry

Array ( [id] => 6617785 [patent_doc_number] => 20100003317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'COMPOSITIONS AND METHODS FOR MEDIATING RNAI IN VIVO' [patent_app_type] => utility [patent_app_number] => 12/412206 [patent_app_country] => US [patent_app_date] => 2009-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 20455 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20100003317.pdf [firstpage_image] =>[orig_patent_app_number] => 12412206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5570402 [patent_doc_number] => 20090253780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'COMPOSITIONS AND METHODS RELATED TO miR-16 AND THERAPY OF PROSTATE CANCER' [patent_app_type] => utility [patent_app_number] => 12/412087 [patent_app_country] => US [patent_app_date] => 2009-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 22694 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253780.pdf [firstpage_image] =>[orig_patent_app_number] => 12412087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5474445 [patent_doc_number] => 20090247611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'METHOD OF TREATING A CANCER WITH A SURVIVIN ANTISENSE OLIGONUCLEOTIDE AND PACLITAXEL' [patent_app_type] => utility [patent_app_number] => 12/403561 [patent_app_country] => US [patent_app_date] => 2009-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4790 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247611.pdf [firstpage_image] =>[orig_patent_app_number] => 12403561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5495326 [patent_doc_number] => 20090263354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'Compositions and siRNAs for inhibiting C/EBPbeta' [patent_app_type] => utility [patent_app_number] => 12/382182 [patent_app_country] => US [patent_app_date] => 2009-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 17992 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20090263354.pdf [firstpage_image] =>[orig_patent_app_number] => 12382182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374836 [patent_doc_number] => 20090312397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'RNAi Modulation Of ApoB And Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/400744 [patent_app_country] => US [patent_app_date] => 2009-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 41202 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312397.pdf [firstpage_image] =>[orig_patent_app_number] => 12400744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6025833 [patent_doc_number] => 20110053862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'COMPOSITIONS COMPRISING SURVIVIN SIRNA AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/921760 [patent_app_country] => US [patent_app_date] => 2009-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22436 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053862.pdf [firstpage_image] =>[orig_patent_app_number] => 12921760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6003364 [patent_doc_number] => 20110118332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'VIRAL MICRORNA' [patent_app_type] => utility [patent_app_number] => 12/736025 [patent_app_country] => US [patent_app_date] => 2009-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8265 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118332.pdf [firstpage_image] =>[orig_patent_app_number] => 12736025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5458775 [patent_doc_number] => 20090258927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'Method for the Modulation of Function of Transcription Factors' [patent_app_type] => utility [patent_app_number] => 12/391943 [patent_app_country] => US [patent_app_date] => 2009-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8687 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258927.pdf [firstpage_image] =>[orig_patent_app_number] => 12391943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6163474 [patent_doc_number] => 20110160282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'NUCLEIC-ACID PHARMACEUTICAL COMPOSITION FOR CANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 12/735809 [patent_app_country] => US [patent_app_date] => 2009-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9576 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160282.pdf [firstpage_image] =>[orig_patent_app_number] => 12735809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048790 [patent_doc_number] => 20110207796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'ALPHA-SYNUCLEIN KINASE' [patent_app_type] => utility [patent_app_number] => 12/865857 [patent_app_country] => US [patent_app_date] => 2009-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 35579 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207796.pdf [firstpage_image] =>[orig_patent_app_number] => 12865857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480181 [patent_doc_number] => 20090203138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'Small Interfering RNAs Targeting Feline Herpes Virus' [patent_app_type] => utility [patent_app_number] => 12/370213 [patent_app_country] => US [patent_app_date] => 2009-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 35220 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203138.pdf [firstpage_image] =>[orig_patent_app_number] => 12370213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6113961 [patent_doc_number] => 20110190386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'Aptamer Inhibitors of Osteopontin and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/867063 [patent_app_country] => US [patent_app_date] => 2009-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17654 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190386.pdf [firstpage_image] =>[orig_patent_app_number] => 12867063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5503014 [patent_doc_number] => 20090163702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'siRNA targeting Myeloid cell leukemia sequence 1' [patent_app_type] => utility [patent_app_number] => 12/378164 [patent_app_country] => US [patent_app_date] => 2009-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 28914 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20090163702.pdf [firstpage_image] =>[orig_patent_app_number] => 12378164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5984597 [patent_doc_number] => 20110097335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'ABC TRANSPORTER PROTEIN EXPRESSION INHIBITOR' [patent_app_type] => utility [patent_app_number] => 12/935847 [patent_app_country] => US [patent_app_date] => 2009-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6874 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20110097335.pdf [firstpage_image] =>[orig_patent_app_number] => 12935847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 185320 [patent_doc_number] => 07645744 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-12 [patent_title] => 'Compositions and methods for siRNA inhibition of HIF-1 alpha' [patent_app_type] => utility [patent_app_number] => 12/359505 [patent_app_country] => US [patent_app_date] => 2009-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9763 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/645/07645744.pdf [firstpage_image] =>[orig_patent_app_number] => 12359505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480810 [patent_doc_number] => 20090203767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'INHIBITION STAT-1' [patent_app_type] => utility [patent_app_number] => 12/358088 [patent_app_country] => US [patent_app_date] => 2009-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11631 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203767.pdf [firstpage_image] =>[orig_patent_app_number] => 12358088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5485368 [patent_doc_number] => 20090275133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'ANTISENSE MODULATION OF C-REACTIVE PROTEIN EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/352572 [patent_app_country] => US [patent_app_date] => 2009-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25457 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275133.pdf [firstpage_image] =>[orig_patent_app_number] => 12352572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7555487 [patent_doc_number] => 08067388 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Decoy-containing pharmaceutical compositions and method of using the same' [patent_app_type] => utility [patent_app_number] => 12/349824 [patent_app_country] => US [patent_app_date] => 2009-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7500 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067388.pdf [firstpage_image] =>[orig_patent_app_number] => 12349824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6183825 [patent_doc_number] => 20110123538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'COMPOSITION COMPRISING EXPRESSION OR ACTIVITY INHIBITORS OF NINJURIN 1 FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASE' [patent_app_type] => utility [patent_app_number] => 12/999005 [patent_app_country] => US [patent_app_date] => 2008-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 8513 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20110123538.pdf [firstpage_image] =>[orig_patent_app_number] => 12999005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8282921 [patent_doc_number] => 08217017 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Modulation of insulin like growth factor I receptor expression' [patent_app_type] => utility [patent_app_number] => 12/342025 [patent_app_country] => US [patent_app_date] => 2008-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 19 [patent_no_of_words] => 32167 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12342025 [rel_patent_id] =>[rel_patent_doc_number] =>)